Clinical Trial Update: Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating carboxyamidotriazole in combination with paclitaxel for advanced solid tumors and refractory lymphomas has completed, examining safety,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Breast Cancer
• Lung Cancer
• Lymphoma
• Melanoma
• Ovarian Cancer
• Renal Cell Carcinoma
• Small Intestine Cancer

Drugs mentioned

• Carboxyamidotriazole (carboxyamidotriazole)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Brain and Central Nervous System Tumors, Breast Cancer | Phase 1 | Status: COMPLETED